Arexvy, the first RSV vaccine approved in the country for this age group, is currently authorised in the US and a further 35 countries. The vaccine’s active ingredient is a recombinant RSV glycoprotein F stabilised in the prefusion conformation (RSVPreF3), combined with GSK’s AS01Eadjuvant...
"We know from the start that this vaccine has durability, which is important versus the COVID vaccine, [which] can lose efficacy after four to six months, reducing public confidence in the vaccine," Dr. Dan Barouch, director of the Center for Virology and Vaccine Research a...
Respiratory syncytial virus (RSV) is a respiratory virus that usually causes mild, cold-like symptoms. Although most people recover in a week or two, infants and older adults are more likely to develop serious RSV and need hospitalization....
Between 100 and 300 children die every year from RSV, as do 6,000 to 10,000 senior citizens, according to the CDC. MORE: Michigan children's hospital says it's 100% full due to RSV surge However, this season there will be protection against RSV offered to many Americ...